Business Context and Reporting Period
CareDx, Inc., a Delaware corporation, filed this Form 8-K on October 10, 2017, to report the closing of its previously announced underwritten public offering of common stock.
Key Financial Metrics
This filing reports on a capital raising event rather than operational financial performance. Key metrics from the offering include:
- Shares Sold: 4,992,840 shares of common stock.
- Over-Allotment: Included 651,240 shares sold pursuant to the underwriters' full exercise of their option.
- Offering Price: $4.00 per share.
- Total Gross Proceeds: Approximately $19.97 million (calculated as 4,992,840 shares x $4.00).
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transactional report.
Material Changes
The primary material change is the increase in the company's outstanding share count and cash assets resulting from the public offering. There is no prior comparable period for this specific transaction within the filing.
Guidance, Outlook, and Risks
The filing incorporates a press release by reference but does not contain specific management commentary, forward-looking guidance, or a detailed discussion of risks within the text provided. The document confirms the company is an emerging growth company.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and commissions (not explicitly stated in this text).
- Review the attached Exhibit 99.1 (Press Release) for details on the intended use of proceeds.
- Confirm the updated total number of outstanding shares post-offering.
- Check subsequent filings for the impact of this capital raise on the company's cash runway and liquidity.